Q32 Bio Inc.
QTTB
$5.94
$0.132.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 155.60% | 162.47% | 30.54% | 8.31% | -30.34% |
| Total Depreciation and Amortization | -25.05% | -19.71% | -14.26% | -7.93% | -2.42% |
| Total Amortization of Deferred Charges | -22.54% | -7.22% | 9.71% | 48.48% | 134.07% |
| Total Other Non-Cash Items | -1,341.14% | -443.23% | 151.64% | 202.67% | 163.47% |
| Change in Net Operating Assets | 78.90% | 58.10% | -177.13% | -126.04% | -135.25% |
| Cash from Operations | 58.25% | 50.46% | 42.10% | -71.26% | -216.64% |
| Capital Expenditure | -- | -- | 97.26% | -275.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 0.00% | 20,418.56% |
| Cash from Investing | -64.70% | -64.87% | -100.01% | -0.44% | 20,341.24% |
| Total Debt Issued | -- | -- | -100.00% | -180.96% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 162.63% | 100.00% |
| Issuance of Common Stock | 511.57% | -- | -99.27% | -96.91% | -95.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -111.72% |
| Cash from Financing | 234.79% | -103.28% | -101.31% | -98.61% | -104.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.55% | -162.66% | -183.73% | -158.99% | -163.24% |